3-[4-fluoro-2-(trifluoromethyl)phenyl]prop-2-enoic Acid → (+/-)-(E)-2-(7-chloro-1'-(3-(4-fluoro-2-(trifluoromethyl)phenyl)acryloyl)-2,3-dihydrospiro[indene-1,4'-piperidine]-3-yl)acetic acid

Participants

Reaction Steps

The title compound was prepared employing a procedure analogous to that described in Example 1 using methyl 2-(7-chloro-2,3-dihydrospiro[indene-1,4′-piperidine]-3-yl)acetate and 4-fluoro-2-(trifluoromethyl)cinnamic acid followed by a procedure analogous to that described in Example 2. LC-MS Method 1 tR=1.95, min, m/z=496, 498; 1H NMR (CDCl3) 1.20-1.40 (3H), 1.70 (m, 1H), 2.40 (m, 1H), 2.53 (m, 1H), 2.65-3.05 (4H), 3.30 (m, 1H), 3.62 (m, 1H), 4.06 (d, 1H), 4.79 (d, 1H), 6.80 (d, 1H), 7.1-7.5 (5H), 7.68 (m, 1H), 7.85 (d, 1H).

Provenance & Evidence